Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Investigation|April 27, 2013
Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectKatherine A Cottrill, Stephen Y Chan
Antioxidants & Redox Signaling|October 12, 2013
Hypoxamirs and mitochondrial metabolismKatherine A Cottrill, Stephen Y Chan, Joseph Loscalzo
Scientific Reports|December 16, 2015
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditionsThomas Bertero, Katherine A Cottrill, Sofia Annis, et al.
Oncotarget|October 15, 2017
Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cellsHilaire C Lam, Heng-Jia Liu, Christian V Baglini, et al.
Circulation|February 29, 2012
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approachVictoria N Parikh, Richard C Jin, Sabrina Rabello, et al.
The Journal of Clinical Investigation|June 25, 2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertensionThomas Bertero, Yu Lu, Sofia Annis, et al.
Cell Reports|November 14, 2015
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 CircuitThomas Bertero, Katherine A Cottrill, Yu Lu, et al.
The Journal of Clinical Investigation|August 23, 2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertensionThomas Bertero, William M Oldham, Katherine A Cottrill, et al.
Pageof 1